Gross Margin
38.56%vs Specialty Chemicals peers Updated Aug 19, 2026Profit Margin
3.11%vs Specialty Chemicals peers Updated Aug 19, 2026Operating Margin
-3.63%vs Specialty Chemicals peers Updated Aug 19, 2026Return on Assets (TTM)
1.82%vs Specialty Chemicals peers Updated Aug 19, 2026Return on Equity (TTM)
2.27%vs Specialty Chemicals peers Updated Aug 19, 2026Revenue (TTM)
712.68MCNY105.85M · vs all stocks (USD) Updated Aug 19, 2026Revenue per Share (TTM)
6.75CNYUpdated Aug 19, 2026Quarterly Revenue Growth
-0.10%vs Specialty Chemicals peers Updated Aug 19, 2026Gross Profit (TTM)
282.93MCNY42.02M · vs all stocks (USD) Updated Aug 19, 2026EBITDA (TTM)
110.92MCNY16.47M · vs all stocks (USD) Updated Aug 19, 2026Net Income (TTM)
22.15MCNY3.29M · vs all stocks (USD) Updated Aug 19, 2026Quarterly Earnings Growth (YoY)
-25.10%vs Specialty Chemicals peers Updated Aug 19, 2026Operating Cash Flow (TTM)
50.64MCNY7.52M · vs all stocks (USD) Updated Aug 19, 2026Levered Free Cash Flow (TTM)
34.07MCNY5.06M · vs all stocks (USD) Updated Aug 19, 2026Forward Annual Dividend Rate
0.1100CNYUpdated Aug 19, 2026Forward Annual Dividend Yield
0.69%Updated Aug 19, 2026Trailing Annual Dividend Rate
0.1050CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.69%Updated Aug 19, 20265-Year Average Dividend Yield
0.70%Updated Aug 19, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 50%.Updated Aug 19, 2026Minority Interest (Equity)
37.98MCNYFY2025 · Dec 31, 2025Revenue
712.82MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
428.82MCNYFY2025 · Dec 31, 2025Gross Profit
284.00MCNYFY2025 · Dec 31, 2025Operating Income
68.05MCNY10.11M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
42.53MCNYFY2025 · Dec 31, 2025Income Tax Expense
6.38MCNYFY2025 · Dec 31, 2025Net Income
36.15MCNYFY2025 · Dec 31, 2025EBIT
51.24MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
110.92MCNYFY2025 · Dec 31, 2025Research & Development
56.43MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
56.84MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.55MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
250.20KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
8.71MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3411CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3405CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
104.99MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
104.99MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
36.15MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-337.83KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
64.39MCNYFY2025 · Dec 31, 2025Free Cash Flow
-24.42MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
64.95MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
36.15MCNYFY2025 · Dec 31, 2025Other Non-cash Items
9.80MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
39.18MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-20.73MCNYFY2025 · Dec 31, 2025Capital Expenditures
-88.81MCNYFY2025 · Dec 31, 2025Net Acquisitions
-5.34MCNYFY2025 · Dec 31, 2025Other Investing Activity
5.16MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-88.99MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
182.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-220.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-8.83MCNYFY2025 · Dec 31, 2025Other Financing Charges
31.46MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-15.37MCNYFY2025 · Dec 31, 2025